Molecular, genomic and mutational landscape of oral leukoplakia

被引:36
作者
Farah, Camile S. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Australian Ctr Oral Oncol Res & Educ, POB 285, Nedlands, WA 6909, Australia
[2] Perth Oral Med & Dent Sleep Ctr, West Leederville, WA, Australia
[3] Fiona Stanley Hosp, Oral Maxiliofacial & Dent Surg, Murdoch, WA, Australia
[4] Australian Clin Labs, Subiaco, WA, Australia
[5] Genom Life, Brisbane, Qld, Australia
关键词
biomarkers; cancer progression; malignant transformation; molecular landscape; oral leukoplakia; precision medicine; PROLIFERATIVE VERRUCOUS LEUKOPLAKIA; POTENTIALLY MALIGNANT DISORDERS; SQUAMOUS-CELL CARCINOMA; DNA-DAMAGE RESPONSE; WORLD WORKSHOP; FOLLOW-UP; EPITHELIAL DYSPLASIA; PREMALIGNANT LESIONS; HUMAN-PAPILLOMAVIRUS; LONG-TERM;
D O I
10.1111/odi.13608
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral leukoplakia (OLK) and its more aggressive clinical variant proliferative verrucous leukoplakia (PVL) remain enigmatic disorders clinically and histopathologically. Despite decades of research into both, there has been only incremental advancement in our understanding of their aetiology and pathogenesis and only minimal improvement in effective management strategies. Currently, no specific prognostic genetic or molecular marker has been reported for leukoplakia. There is, however, an emerging body of evidence characterising the genomic and transcriptomic profile of OLK. Regardless of the significance of cellular and architectural features of OLK and PVL, it is clear from studies reported in this review that new emerging evidence points to the presence of premalignant molecular subtypes of leukoplakia which require further investigation. This up-to-date review explores the contemporary genomic, transcriptomic and mutational landscape of leukoplakia broadly, discusses concepts that may not be widely recognised or accepted and purposefully highlights studies with juxtaposed findings in an effort to challenge dogma. It also highlights the urgent need for a concerted international effort of original collaborative research which will only occur by pooling collective efforts, resources and intellect to define the molecular fingerprint of this enigmatic disorder, in the hope it will better inform diagnosis, stratification and treatment.
引用
收藏
页码:803 / 812
页数:10
相关论文
共 87 条
[1]   Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature [J].
Abadie, Wesley M. ;
Partington, Erin J. ;
Fowler, Craig B. ;
Schmalbach, Cecelia E. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 153 (04) :504-511
[2]   Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma-a clinical, histologic and immunohistochemical study [J].
Akrish, Sharon ;
Ben-Izhak, Ofer ;
Sabo, Edmond ;
Rachmiel, Adi .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2015, 119 (03) :318-325
[3]   Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders [J].
Alaizari, Nader A. ;
Sperandio, Marcelo ;
Odell, Edward W. ;
Peruzzo, Daiane ;
Al-Maweri, Sadeq A. .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (02) :97-103
[4]   Marked variation in malignant transformation rates of oral leukoplakiaQuestion: What is the malignant transformation rate of oral leukoplakia? [J].
Aisling Anderson ;
Nurul Ishak .
Evidence-Based Dentistry, 2015, 16 (4) :102-103
[5]  
[Anonymous], 2017, WHO CLASSIFICATION H
[6]   Proliferative verrucous leukoplakia: a concise update [J].
Bagan, J. ;
Scully, C. ;
Jimenez, Y. ;
Martorell, M. .
ORAL DISEASES, 2010, 16 (04) :328-332
[7]   Second primary tumors in proliferative verrucous leukoplakia: a series of 33 cases [J].
Bagan, Jose ;
Murillo-Cortes, Judith ;
Poveda-Roda, Rafael ;
Leopoldo-Rodado, Manuel ;
Bagan, Leticia .
CLINICAL ORAL INVESTIGATIONS, 2020, 24 (06) :1963-1969
[8]  
Bagan J, 2019, J PERIODONTOL, V90, P1142, DOI [10.1002/WER.18-0620, 10.1002/JPER.18-0620]
[9]   Mouthwash use and cancer of the head and neck: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium [J].
Boffetta, Paolo ;
Hayes, Richard B. ;
Sartori, Samantha ;
Lee, Yuan-Chin A. ;
Muscat, Joshua ;
Olshan, Andrew ;
Winn, Deborah M. ;
Castellsague, Xavier ;
Zhang, Zuo-Feng ;
Morgenstern, Hal ;
Chen, Chu ;
Schwartz, Stephen M. ;
Vaughan, Thomas L. ;
Wunsch-Filho, Victor ;
Purdue, Mark ;
Koifman, Sergio ;
Curado, Maria P. ;
Vilensky, Marta ;
Gillison, Maura ;
Fernandez, Leticia ;
Menezes, Ana ;
Daudt, Alexander W. ;
Schantz, Stimson ;
Yu, Guopei ;
D'Souza, Gypsyamber ;
Haddad, Robert I. ;
La Vecchia, Carlo ;
Hashibe, Mia .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2016, 25 (04) :344-348
[10]   Prognostic value of DNA ploidy status in patients with oral leukoplakia [J].
Bremmer, Jantine F. ;
Brakenhoff, Ruud H. ;
Broeckaert, Mark A. M. ;
Belien, Jeroen A. M. ;
Leemans, C. Rene ;
Bloemena, Elisabeth ;
van der Waal, Isaac ;
Braakhuis, Boudewijn J. M. .
ORAL ONCOLOGY, 2011, 47 (10) :956-960